financetom
Business
financetom
/
Business
/
Market Chatter: General Motors Reviews Option to Drop Lithium-Iron Phosphate Batteries for Electric Vehicles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: General Motors Reviews Option to Drop Lithium-Iron Phosphate Batteries for Electric Vehicles
Jun 11, 2026 3:37 AM

06:16 AM EDT, 06/11/2026 (MT Newswires) -- General Motors ( GM ) might abandon its previous strategy to use lower-cost, iron-based battery chemistry for upcoming electric vehicles, Reuters reported Wednesday, citing comments from the company's head of battery technology, Kurt Kelty.

The company previously disclosed plans to create lithium-iron phosphate batteries for models coming in the future at a combined manufacturing facility in Tennessee starting late next year, the report said.

General Motors ( GM ) is now shifting its attention to using a lithium manganese-rich technology instead, which offers comparable manufacturing costs in the US but provides higher energy storage capacity, Reuters quoted Kelty as saying.

The Tennessee factory will begin manufacturing LFP cells this month solely for energy storage configurations rather than automotive applications, the report said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zai Lab's Schizophrenia Drug Application Accepted by Chinese Regulator; Shares Rise
Zai Lab's Schizophrenia Drug Application Accepted by Chinese Regulator; Shares Rise
Jan 17, 2025
10:20 AM EST, 01/17/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said Friday that its new drug application for KarXT to treat adult patients with schizophrenia was accepted by China's National Medical Products Administration. The application is backed by results from a phase 1 China pharmacokinetics study, the phase 3 China study and data from global Emergent clinical programs,...
Goldman Sachs Raises CEO David Solomon's Compensation to $39 Million in 2024
Goldman Sachs Raises CEO David Solomon's Compensation to $39 Million in 2024
Jan 17, 2025
10:23 AM EST, 01/17/2025 (MT Newswires) -- Goldman Sachs Group ( GS ) said in a regulatory filing Friday its board has approved to increase Chief Executive David Solomon's total annual compensation to $39 million in 2024 from $31 million in 2023. Solomon and Chief Operating Officer John Waldron were also given restricted stock units valued at $80 million each...
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations
Jan 17, 2025
10:27 AM EST, 01/17/2025 (MT Newswires) -- Bausch Health Companies ( BHC ) , down near 1% at last look, on Friday said the Centers for Medicare and Medicaid Services (CMS) has selected Xifaxan (rifaximin) 550 mg tablets for the second round of negotiation as part of the Inflation Reduction Act. We look forward to engaging in open and transparent...
US Treasury Dept issues sanctions related to Salt Typhoon hack
US Treasury Dept issues sanctions related to Salt Typhoon hack
Jan 17, 2025
WASHINGTON (Reuters) - The U.S. Treasury department on Friday issued cyber-related sanctions related to the Salt Typhoon hack on Singaporean Yin Kechen and cybersecurity company Sichuan Juxinhe Network Technology Co., according to a statement. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved